Genotoxic effects induced by fotemustine and vinorelbine in human lymphocytes

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 61, Issue 11-12, 2006, Pages 903-910

  Çelikler, Serap ^a   Bilaloǧlu, Rahmi ^a   Aydemir, Nilüfer ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Fotemustine; Genotoxicity; Vinorelbine (Navelbine)

Indexed keywords

VINCA;

EID: 33846504995     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2006-11-1220     Document Type: Article

References (25)

1. Aldridge J. E., Gibbons J. A., Flaherty M. M., Kreider M. L., Romano J. A., and Lewin A. D. (2003), Heterogeneity of toxicant response: Sources of human variability. Toxicol. Sci. 76, 3-20.
2. Ashby J., Vogel E. W., Tinwell H., Callander R. D., and Shuker D. E. G. (1993), Mutagenicity to Salmonella, Drosophila and mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency. Mutat. Res. 286, 101-109.
3. Bolzan A. D. and Bianchi M. S. (2002), Chromosomal response of human lymphocytes to streptozotocin. Mutat. Res. 503, 63-68.
4. Bunn A. Jr and Kelly K. (1998), New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin. Cancer Res. 4, 1087-1100.
5. 6-alkylguanine-DNA transferase in blood lymphocytes and in tumors. Ann. Oncol. 10, 831-838.
6. Gonzalez-Cid M., Cuello M. T., and Larripa I. (1997), Vinorelbine: cell cycle kinetics and differential sensitivity of human lymphocyte subpopulations. Toxicol. Lett. 93, 171-176.
7. Gonzalez-Cid M., Cuello M. T., and Larripa I. (1999), Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes. Mutagenesis 14, 63-66.
8. Ingelman-Sundberg M. (2001), Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat. Res. 482, 11-19.
9. Kirsch-Volders M. and Fenech M. (2001), Inclusion of micronuclei in non-divided mononuclear lymphocytes and necrosis/apoptosis may provide a more comprehensive cytokinesis block micronucleus assay for biomonitoring purposes. Mutagenesis 16, 51-58.
10. Lopez-Nigro M. M., Palermo A. M., Mudry M. D., and Carballo M. A. (2003), Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol. in vitro 17, 35-40.
11. 6- Alkylguanine-DNA alkyltransferase: role in carcinogenesis and chemotherapy. BioEssays 24, 255-266.
12. Marzolini C., Decosterd L. A., Shen F., Gander M., Leyuraz S., Bauer J., Buclin T., Biollaz J., and Lejeune F. (1998), Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous and hepatic intra arterial administration. Cancer Chemother. Pharmacol. 42, 433-440.
13. Natarajan A. T. (2002), Chromosome aberrations: past, present and future. Mutat. Res. 504, 3-16.
14. Ngan V. K., Bellman K., Hill B. T., Wilson L., and Jordan M. A (2001), Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic Vinca alkaloids vinorelbine and its newer derivative vinflunine. Mol. Pharmacol. 60, 225-232.
15. Pacchierotti F., Bassani B., Leopardi P., and Zijno A. (1991), Origin of aneuploidy in relation to disturbances of cell-cycle progression. II: Cytogenetic analysis of various parameters in mouse bone marrow cells after colchicines or hydroquinone treatment. Mutagenesis 6, 307-311.
16. Parry P. and Wolf S. (1974), New Giemsa method for differential staining of sister chromatids. Nature 251, 156-158.
17. Rainaldi G., Flori L., Colella C. M., Mariani T., Piras A., Simi S., and Simili M. (1987), Analyses by BrUdR-labelling technique of induced aneuploidy in mammalian cells culture. Mutat. Res. 177, 255-260.
18. Sbrana I., Disibio A., Lomi A., and Scarcelli V. (1993), C-Mitosis and numerical chromosome aberration analyses in human lymphocytes: 10 known or suspected spindle poisons. Mutat. Res. 287, 57-70.
19. Terracini B., Pastore G., Zurlo M. G., Masera G., Fussati-Bellani F., Castello M., Tamaro P., Massolo F., Rosati D., and Biddan P. F. (1987), Late deaths and second primary malignancies among long-term survivors of childhood cancer: an Italian multi-centre study. Eur. J. Cancer Clin. Oncol. 23, 499-504.
20. Tiburi M., Reguly M. L., Schwartsmann G., Cunha K. S., Lehmann M., and de Andrade H. H. R. (2002), Comparative genotoxic effect of vincristine, vinblastine and vinorelbine in somatic cells of Drosophila melanogaster. Mutat. Res. 519, 141-149.
21. Tucker J. D. and Preston R. J. (1996), Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchange and cancer risk assessment. Mutat. Res. 365, 147-159.
22. Vermeulen N. P. E., Commandeur J. N. M., Groot E. J., Wormhoudt L. W., Ramnatshing S., Li Q. J., and Brakenhoff J. P. G. (1998), Toxicicty of fotemustine in rat hepatocytes and mechanism-based protection against it. Chem. Biol. Interact. 110, 139-158.
23. Winum J. Y., Bouissière J. L., Passagne I., Evrard A., Montero V., Cuq P., and Montero J. L. (2003), Synthesis and biological evaluation of fotemustine analogues on human melanoma cell lines. Eur. J. Med. Chem. 38, 319-324.
24. Wolff S. (ed.) (1982), Sister chromatid exchange. John Wiley and Sons, New York, NY.
25. Zhou X. J. and Rahmani R. (1992), Preclinical and clinical pharmacology of Vinca alkaloids. Drugs 44, 1-16.